<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>创新药 on Fenglai</title><link>http://zssite.online/tags/%E5%88%9B%E6%96%B0%E8%8D%AF/</link><description>Recent content in 创新药 on Fenglai</description><generator>Hugo -- 0.128.0</generator><language>zh-cn</language><lastBuildDate>Mon, 31 Aug 2026 14:30:00 +0800</lastBuildDate><atom:link href="http://zssite.online/tags/%E5%88%9B%E6%96%B0%E8%8D%AF/index.xml" rel="self" type="application/rss+xml"/><item><title>投资基础｜72. 医药生物股怎么估值？创新药管线 rNPV、器械 PE、CRO PEG</title><link>http://zssite.online/posts/%E6%8A%95%E8%B5%84%E5%9F%BA%E7%A1%80-72-%E5%8C%BB%E8%8D%AF%E7%94%9F%E7%89%A9%E4%BC%B0%E5%80%BC/</link><pubDate>Mon, 31 Aug 2026 14:30:00 +0800</pubDate><guid>http://zssite.online/posts/%E6%8A%95%E8%B5%84%E5%9F%BA%E7%A1%80-72-%E5%8C%BB%E8%8D%AF%E7%94%9F%E7%89%A9%E4%BC%B0%E5%80%BC/</guid><description>医药生物是A股最「分裂」的行业——同一个板块里，创新药看管线价值、器械看利润、CRO看订单增速，用错方法误差巨大。</description></item></channel></rss>